BioSpace News Archive

Astex Pharmaceuticals, Inc. announces today top-line results from the ASCERTAIN phase 3 study evaluating oral decitabine and cedazuridine fixed-dose combination (ASTX727 or DEC-C) tablets versus IV decitabine in adults with AML who are not candidates to receive standard induction chemotherapy.

CANbridge Pharmaceuticals, Inc. (HKEX:1228), announced that data from its CAN106 Phase 1 trial will be presented at the 2022 European Hematology Association Congress, in Vienna, Austria, on June 10th.

Antengene Corporation Limited announces that the Chinese Society of Clinical Oncology, the most prominent medical society for oncology in China, has added multiple XPOVIO® regimens for the treatment of relapsed/refractory multiple myeloma and relapsed/refractory diffuse large B-cell lymphoma to its 2022 Guidelines for the Diagnosis and Treatment of Hematologic Malignancies and 2022 Guidelines for the Diagnosis and Treatment of Lymphomas.

The global humanized mouse model market is estimated to gain a valuation of US$ 188.57 Mn by 2027.

Albany NY, United States: The global galectin inhibitor therapeutics market is anticipated to expand at a promising rate from 2021 to 2031.

The professional intelligence report on the global exosome diagnostic and therapeutic market predicts that the industry will witness an outstanding CAGR of 36.6 % over the forecast period of 2020 to 2027.

Albany NY, United States: The concession market may witness exponential growth during the forecast period of 2021-2031 owing to the rising incidences of sports injuries, road accidents, and the growing geriatric population across the globe.

The global clinical laboratory tests market was evaluated at US$ 176.7 billion at the beginning of the forecast period i.e. in 2019.

The global super absorbent dressings market is expected to witness strong growth during the forecast period between 2021 and 2031.

Albany NY, United States: The global neoantigens market is expected to expand at a healthy rate from 2021 to 2031.